News & Events

JHL Biotech Focuses on CDMO and Biologics Development for Global Markets After Spinoff

HSINCHU, Taiwan, February 26, ... read more →

• 2 月 26, 2020

JHL Biotech Analytical Bioassay Lab Expansion Project

JHL’s AD-Bio Lab has recently ... read more →

• 2 月 3, 2020

JHL Focusing on NEW Biosimilar Pipeline and Global Expansion of CDMO Business

HSINCHU, Taiwan and WUHAN, Chi... read more →

• 8 月 16, 2019

JHL Biotech Announces Completion of Convertible Bond Issuance

HSINCHU, Taiwan and WUHAN, Chi... read more →

• 6 月 13, 2018

China: Sequoia-backed biopharma startup JHL Biotech raises $106m

• 5 月 29, 2018

JHL Biotech’s Application to Voluntarily Terminate Trading of Shares Approved by Taipei Exchange

HSINCHU, Taiwan and WUHAN, Chi... read more →

• 2 月 3, 2018

JHL Biotech Welcomes New Chief Medical Officer, Rong Chen

HSINCHU, Taiwan and WUHAN, Chi... read more →

• 1 月 1, 2018

JHL Awarded top 20 Deloitte 2017 Asia Technology Fast 500 TM

JHL Biotech, Inc. (“JHL”, 6540... read more →

• 12 月 13, 2017

Sanofi and JHL Biotech Announce Strategic Biologics Alliance in China

Shanghai, China - 5 December 2... read more →

• 12 月 5, 2016

JHL Biotech and Aslan Pharmaceuticals to Partner on Manufacturing Services for Aslan004

Singapore and Hsinchu, Taiwan,... read more →

• 11 月 14, 2016

下一頁 »